Oncolix Inc. (fka ONCX)

[laraz5]

SAD :(.. Times that Oncolix Shareholders are now being led to believe that the CEO and creator on this conglomerate of Dilution and Toxic Finance is no longer in control of the Company he created?

Michael T Redman no longer has controlling Interest of his own Company but 4 months after going Public? IS that the nonsense that ONCX is trying to peddle? When the empty shell as purchased from career criminal Brian Kistler and he was paid off to leave, who received the majority of the shares? Was it Redman Or GHS, one would have to go look at the buyout filing all over to see where 61,000,000 million shares were issue to?

Has Redman really sold his entire Interest of Oncolix into the hands of Toxic Financers and is taking the coward way out in claiming he has no say in the very company he is listed as Owner/CEO/COO?

Is that what happened in the failed phase 1 clinical trials? That ended last month, Is Redman really blaming GHS for the failure and the lack of leadership and transparecy? Does GHS have a history of non disclusure and failures? Where are the results for phase 1? where are the numbers? where is the efficiancy readings?

Why is there no Information on a concluded study of PRolanta?

Now, who is the one making up the lies about silly misleading fake cohorts? the United States Governing body of Clinical Trials has Prolanta as Concluded/Over?

So where is the Information on the weird Cohort phase 1 extension? Why is the governing body of the USA un aware and unlisting this current Cohort, are they not aware?

Oncolix was able to pull off the nonsense previously because the empty vessel sat in phase 1 for two years but not anymore, I'm asking Michael T Redman or If GHS is in Control where is the link to show the extension of phase 1..?

Mike...Here is the link to show your trial has concluded..You're up?

https://clinicaltrials.gov/ct2/show/NCT02534922

Study Start Date : February 2016
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : January 2018

When Novartis actually tested human prolactin receptor antagonist on 73 patients and it failed, all the information is readily available but not for Oncolix?

Stop the lies Oncolix, you baited shareholders from .19 and switched there share value to .04 and still have nothing to show for it but a raise in the A/S and now you want to abandon Ovarian Cancer and switch to another form?

You Animals, stop the lies?

Stop the lies?

IMO